• br Conflicts of interest br The authors declare no

  2022-07-28

  

  Conflicts of interest The authors declare no conflict of interest. Author contribution Acknowledgements References Derdak, Z., Fulop, P., Sabo, E., Tavares, R., Berthiaume, E.P., Resnick, M.B., Paragh, G., Wands, J.R., Baffy, G., 2006. Enhanced colon tumor induction in uncoupling pro

• br Di erences between bone

  2022-07-28

  

  Differences between bone T-5224 distributions of breast cancer and lung cancer may show the discrepancy between the vertebral ve-nous plexus spreading bone metastasis pattern of tumors in thoracic cavity and out of thoracic cavity, which may reflect different drainage routes of vertebral venous ple

• Ctthe NC group DCT Ctgene Ctinternal

  2022-07-28

  

  Ctthe NC group, DCT = Ctgene Ctinternal control.49 The cycle threshold (Ct) was considered to be reflective of the number of amplification cycles when the real-time fluorescence intensity reached the set threshold, and the amplification was logarithmic. The primers used in the reaction are displa

• br In this work we prepared bombesin conjugated EGCG

  2022-07-28

  

  In this work, we prepared bombesin conjugated, EGCG loaded solid lipid nanoparticles by the double-emulsification solvent evaporation  method followed by conjugation using EDC–NHS reaction. FTIR ana-lysis validated the formation of the amide bond between the carboxylic C–O group of the lipid

• br Photothermal performances of BPNs PDA

  2022-07-26

  

  2.2. Photothermal performances of BPNs-PDA-PEG-PETIC. The UV–vis-NIR spectroscopy of BPNs-PDA-PEG-PEITC solutions with different concentrations was shown in Fig. 2a. An obvious ab-sorption at NIR wavelength indicating the potential application in tumor PTT. BPNs-PDA-PEG-PEITC with different con

• Diphenylterazine br Introduction br Recently paclitaxel PTX preparations which

  2022-07-25

  

  1. Introduction Recently, paclitaxel (PTX) preparations, which are effective for the treatment of various tumors such as breast cancer, non-small cell lung cancer, and ovarian cancer have been widely used and studied [1,2]. This anticancer agent exerts a tumor effect by polymerizing tubulin monom

• br O Lopez Ocejo A Viloria Petit

  2022-07-25

  

  [57] O. Lopez-Ocejo, A. Viloria-Petit, M. Bequet-Romero, D. Mukhopadhyay, J. Rak, R.S. Kerbel, Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner, Oncogene 19 (2000) 4611e4620. S.J. Mansou

• br RNA seq data and qPCR analyses confirmed

  2022-07-06

  

  RNA-seq data and qPCR analyses confirmed regulation of BACH1’s previously known—and new Transfac-identified—target genes. For example, Nqo1 expression was lower, and Pkp3 and Mmp1a expression was higher, in mTN than mTC C11 BODIPY 581/591 (Figure 2C). Pkp3 and Mmp1a have been linked to cell in

• br The numbers of practical barriers and facilitators listed by

  2022-06-21

  

  1. The numbers of practical barriers and facilitators listed by women will more strongly relate to screening status than the number of psychological barriers. 2. Specifically, a lack of time (practical barrier) and GP status (prac-tical facilitator) will be most strongly related to women's scre

• br CHFR was methylated in

  2022-05-30

  

  CHFR was methylated in 15.7% of patients with metastatic CRC in our study, and this was lower than in previous studies reporting CHFR methylation in 31%-63% of patients, mostly with stage I- III CRC [18,19,21,22,37]. When we analyzed the TCGA dataset, CHFR methylation levels did not differ by t

• br inhibitors W stemann et al Thus

  2022-05-25

  

  inhibitors (Wüstemann et al., 2016). Thus, the general radio-biokinetic models for iPSMA in the CS and Cy of LNCaP D-Luciferin were established as 3. Results and discussion Table 3 Average radiation absorbed dose values (Gy/Bq) of the 225Ac, 223Ra and their progeny, as well as that of

• br Breast cancer survivors had significantly decreased right

  2022-05-25

  

  Breast cancer survivors had significantly decreased right and left hand grip strengths compared to healthy women. However, non-breast cancer survivors did not have significantly lower hand grip strength than healthy participants. A previous study also showed similar results; the grip strength of y

• br aspirin treatment Fig E Western blot

  2022-05-23

  

  aspirin treatment (Fig. 3E). Western blot coupled with ELISA (Fig. 3F) indicated that the hypoxia-mediated activation of HIF-1α/COX-2/PGE2 signaling could be attenuated by aspirin; the second and third genera-tions of ALDH+ Biotin-HPDP showed similar results (Supplementary Fig. 1). These findings

• br JOURNAL PRE PROOF br boron based

  2022-05-23

  

  JOURNAL PRE-PROOF boron-based prodrugs is central since none of these molecules has entered clinical trial so far. In this work, we decided to develop potent arylboronate-drug conjugates and further select the most receptive target among several cancer cell lines in order to identify the type o

• Doxorubicin br have been previously developed

  2022-05-23

  

  have been previously developed and reported in the literature (i.e., [10, 14]), these schemes computed image features from a fixed region of interest (ROI) covering the suspicious lesions, which have disadvantages or difficult to adaptively identify the optimal size of the ROIs to cover the lesion

149 records 1/10 page Next 12345 Next 5 pages Last page